... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Bladder cancer Urothelial cancer Non-muscle invasive bladder cancer Heart...

...-free survival (PFS) after urological cancers. Results: A total of 20 studies were eligible. Three studies were on bladder cancer, four on prostate cancer, seven on renal cell carcinoma (RCC), and six on urothelial cancers. Meta-analysis showed that low GNRI was a statistically significant predictor...

... Bladder cancer Urothelial cancer MIBC BCG Gender Following the 2018 GLOBOCAN data, urothelial carcinoma of the bladder is the 10th most common malignancy worldwide, with 549,393 new cases and 200,000 cancer-related deaths. In the USA, bladder cancer comprises 5% of new cancer diagnoses...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Urothelial cancer Prognostic nutritional index Controlling nutritional status Geriatric nutritional risk index Survival The current review protocol was registered...

..., it is associated with a poorer prognosis [3, 4]. Urothelial cancer Bladder cancer Upper urinary tract carcinoma Surgical margin Fresh frozen analysis Bladder cancer (BC) is the 7th most commonly diagnosed cancer in males worldwide [1]. It is characterized by a high rate of recurrence...

... epidermal growth factor receptor 2 ERBB2 gene Urothelial cancer Bladder Trastuzumab Patients with metastatic urothelial carcinoma (UC) show poor response rates to platinum-based chemotherapy as the current standard treatment of care, resulting in a median survival of about 14 months [ 1...

... to in the content or advertisements. Local recurrence Muscle-invasive bladder cancer Surgical treatment Urothelial cancer One patient received neoadjuvant chemotherapy before cystectomy. Limits of the PLND comprised the pelvic side-wall between the genitofemoral and obturator nerves, the crossing...

...Axel Hegele; Peter Goebell; Ullrich Matz; Thomas Neuhaus Objective: The objective of this retrospective study was to investigate the efficacy and safety of vinflunine monotherapy and the utility of second-line prognostic factors in patients with advanced or metastatic urothelial cancer relapsing...

...Mikio Igawa; Hitoshi Kadena; Takatoshi Tacho; Takahisa Nakamoto; Tsuguru Usui Thirty-seven patients with urothelial cancer were given combination chemotherapy with methotrexate, etoposide and cisplatin. Thirty patients were evaluated for response. Response rates were 50% in the primary organ, 50...

... and hematuria and 3 individuals exhibited hematuria alone. Cold cup biopsies revealed transitional cell carcinoma in 7 of 9 patients with papillary tumors and in 2 of 3 with nonpapillary tumors. Four patients without ureteroscopic diagnosis of urothelial cancer were found to have invasive tumors on subsequent...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Gene amplification Double minute chromosomes Urothelial cancer Original Paper Urol Int 1992:48:258-260 Jelena Milasin3...

... of UUT TCC patients, in addition to factors such as tumor grade, stage and size. 19 11 2007 28 01 2008 11 5 2009 Upper urinary tract tumors Urothelial cancer Radical nephroureterectomy Open conservative surgery © 2009 S. Karger AG, Basel 2009 Copyright / Drug Dosage...

... between human urothelial cancer cells and cytokine-activated human endothelial cells. Materials and Methods: We studied the expression of sLe x and sLe a antigens of three bladder cancer cell lines (JTC 30, JTC 32, and T24) by flow cytometry and the adherence to interleukin 1β-activated human umbilical...